Wednesday, November 18, 2026 Vol. I · No. 6
World · Via South China Morning Post

Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

Image: South China Morning Post

Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a local biotech start-up. Yicura BioMed, based in the Hong Kong Science Park, is heading towards an initial…

This is a brief. The reporting belongs to South China Morning Post — read the complete story, with full context and credits, at the source.

Read the full story at South China Morning Post ↗

scmp.com

More from the World desk